Organophosphorus Poisoning Treatment: Anti-sialogogue Action

Acute organophosphorus poisoning causes an overload of the neurotransmitter acetylcholine ($ACh$) at nerve synapses due to the inhibition of acetylcholinesterase. This leads to a cholinergic crisis with symptoms like excessive salivation (sialorrhea), bradycardia, bronchoconstriction, and muscle weakness.

Atropine's Role as Anti-sialogogue and Parasympatholytic

The primary drug used to counteract the muscarinic effects of organophosphorus poisoning, such as excessive salivation and secretions, is atropine.

• Mechanism: Atropine is a competitive antagonist of acetylcholine at muscarinic receptors. By blocking these receptors, it inhibits the parasympathetic nervous system's overstimulation.
• Anti-sialogogue Effect: It effectively reduces secretions, including saliva, tears, and bronchial mucus, directly addressing the symptom of sialorrhea.
• Peripheral Parasympatholytic Action: It blocks parasympathetic effects throughout the body, helping to manage symptoms like bradycardia and bronchospasm caused by $ACh$ excess.

Analysis of Other Options

• Carbamates: These are also cholinesterase inhibitors and would worsen the poisoning.
• Benzodiazepine: Used for seizures or agitation, not for direct muscarinic symptoms like salivation.
• Pralidoxime: An acetylcholinesterase reactivator, crucial for treating the underlying enzyme inhibition, but it does not have the direct anti-sialogogue or peripheral anticholinergic effects of atropine. It primarily addresses nicotinic symptoms and helps regenerate enzyme function.

Therefore, atropine is the correct choice for its anti-sialogogue and peripheral parasympatholytic properties in managing organophosphorus poisoning.